Soluble tumor necrosis factor (TNF) receptors conserve TNF bioactivity in meningitis patient spinal fluid

Journal of Infectious Diseases

Volumn 174, Issue 3, 1996, Pages 557-563

  Møller, Bjarne ^a   Ellermann Eriksen, Svend ^b   Storgaard, Merete ^b   Obel, Niels ^b   Bendtzen, Klaus ^b   Petersen, Claus Munck ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; ASEPTIC MENINGITIS; BACTERIAL MENINGITIS; CEREBROSPINAL FLUID CYTOLOGY; CLINICAL ARTICLE; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; RECEPTOR BINDING;

EID: 0029775794     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.3.557     Document Type: Article

References (27)

1. Beutler B, Grau GE. Tumor necrosis factor in the pathogenesis of infectious diseases. Crit Care Med 1993;21:S423-35.
2. Hofsli E, Bakke O, Nonstad U, Espevik T. A flow cytometric and immunofluorescence microscopic study of tumor necrosis factor production and localization in human monocytes. Cell Immunol 1989;122:405-15.
3. Tracey KJ, Cerami A. Tumor necrosis factor: an updated review of its biology. Crit Care Med 1993;21:S415-22.
4. Shapiro L, Clark BD, Orencole SF, Poutsiaka DD, Granowitz EV, Dinarello CA. Detection of tumor necrosis factor soluble receptor p55 in blood samples from healthy and endotoxemic humans. J Infect Dis 1993;167:1344-50.
5. Kem P, Hemmer CJ, Gallati H, et al. Soluble tumor necrosis factor receptors correlate with parasitemia and disease severity in human malaria. J Infect Dis 1992;166:930-46.
6. Aderka D, Engelmann H, Shemer Avni Y, et al. Variation in serum levels of the soluble TNF receptors among healthy individuals. Lymphokine Cytokine Res 1992;11:157-9.
7. Engelmann H, Aderka D, Rubinstein M, Rotman D, Wallach D. A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity. J Biol Chem 1989;264:11974-80.
8. Olsson I, Lantz M, Nilsson E, et al. Isolation and characterization of a tumor necrosis factor binding protein from urine. Eur J Haematol 1989;42:270-5.
9. Lesslauer W, Tabuchi H, Gentz R, et al. Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality. Eur J Immunol 1991;21:2883-6.
10. Mohler KM, Torrance DS, Smith CA, et al. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol 1993;151:1548-61.
11. Narhi LO, Arakawa T. Dissociation of recombinant tumor necrosis factor-α studied by gel permeation chromatography. Biochem Biophys Res Commun 1987;147:740-6.
12. Petersen CM, Nykjaer A, Christiansen BS, Heickendorff L, Mogensen SC, Møller B. Bioactive human recombinant tumor necrosis factor-α: an unstable dimer? Eur J Immunol 1989;19:1887-94.
13. Corti A, Fassina G, Marcucci F, Barbanti E, Cassani G. Oligomeric tumour necrosis factor alpha slowly converts into inactive forms at bioactive levels. Biochem J 1992;284:905-10.
14. Schoenfeld HJ, Poeschl B, Frey JR, et al. Efficient purification of recombinant human tumor necrosis factor beta from Escherichia coli yields biologically active protein with a trimeric structure that binds to both tumor necrosis factor receptors. J Biol Chem 1991;266:3863-9.
15. Moller B, Mogensen SC, Wendelboe P, Bendtzen K, Petersen CM. Bioactive and inactive forms of tumor necrosis factor-α in spinal fluid from patients with meningitis. J Infect Dis 1991;163:886-9.
16. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 1992;175:323-9.
17. Hwu P, Schwarz S, Custer M, Smith CA, Mule JJ, Rosenberg SA. Use of soluble recombinant TNF receptor to improve detection of TNF secretion in cultures of tumor infiltrating lymphocytes. J Immunol Methods 1992;151:139-47.
18. Ellermann-Eriksen S. Autocrine secretion of interferon-alpha/beta and tumour necrosis factor-alpha synergistically activates mouse macrophages after infection with herpes simplex virus type 2. J Gen Virol 1993;74:2191-9.
19. 50 in different types of human leukocytes in vitro. Br J Clin Pharmacol 1990;29:93-100.
20. Jones EY, Stuart DI, Walker NP. The structure of tumour necrosis factor-implications for biological function. J Cell Sci Suppl 1990;13:11-8.
21. Eck MJ, Sprang SR. The structure of tumor necrosis factor-α at 2.6 Å resolution. Implications for receptor binding. J Biol Chem 1989;264:17595-605.
22. Smith RA, Baglioni C. The active form of tumor necrosis factor is a trimer. J Biol Chem 1987;262:6951-4.
23. Porteu F, Nathan C. Shedding of tumor necrosis factor receptors by activated human neutrophils. J Exp Med 1990;172:599-607.
24. Porteu F, Hieblot C. Tumor necrosis factor induces a selective shedding of its p75 receptor from human neutrophils. J Biol Chem 1994;269:2834-40.
25. Banner DW, D'Arcy A, Janes W, et al. Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: implications for TNF receptor activation. Cell 1993;73:431-45.
26. Pennica D, Lam VT, Weber RF, et al. Biochemical characterization of the extracellular domain of the 75-kilodalton tumor necrosis factor receptor. Biochemistry 1993;32:3131-8.
27. Corti A, Poiesi C, Merli S, Cassani G. Tumor necrosis factor (TNF) alpha quantification by ELISA and bioassay: effects of TNFα-soluble TNF receptor (p55) complex dissociation during assay incubations. J Immunol Methods 1994;177:191-8.